Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study (Q40297061)

19 September 2017

title

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study (English)

1 reference

19 September 2017

1 reference

3

Tiina Laatikainen

0 references

Miia Kivipelto

object named as

Miia Kivipelto

series ordinal

1

0 references

Jaakko Tuomilehto

series ordinal

6

object named as

Jaakko Tuomilehto

1 reference

19 September 2017

5

Hilkka Soininen

1 reference

19 September 2017

4

Bengt Winblad

1 reference

19 September 2017

Tiia Ngandu

2

1 reference

19 September 2017

publication date

1 September 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

5

1 reference

19 September 2017

issue

9

1 reference

19 September 2017

page(s)

735-741

1 reference

The incidence of dementia: a meta-analysis

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Worldwide prevalence and incidence of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The Dundee coronary risk-disk for management of change in risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The Framingham prediction rule is not valid in a European population of treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Controlled trial of effect of documented cardiovascular risk scores on prescribing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

An 18-year follow-up of overweight and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Association of diabetes mellitus and dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970537-3

7 January 2021

10.1016/S1474-4422(06)70537-3

Identifiers

DOI

1 reference

19 September 2017

1 reference